AP601

· AP Biosciences Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AP601, covering 2025-12-29 to 2025-12-29. Get the full timeline:

Most recent: Clinical Trial Update: A Study of AP601 in Patients With Locally Unresectable Advanced or Metastatic Solid Tumors [Phase 1]